Butzow R - Search Results

1

Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma.

Lassus H, Staff S, Leminen A, Isola J, Butzow R. Lassus H, et al. Among authors: butzow r. Gynecol Oncol. 2011 Jan;120(1):11-7. doi: 10.1016/j.ygyno.2010.09.003. Gynecol Oncol. 2011. PMID: 20937525

2

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.

Tapper J, Bützow R, Wahlström T, Seppälä M, Knuutila S. Tapper J, et al. Among authors: butzow r. Br J Cancer. 1997;75(12):1782-7. doi: 10.1038/bjc.1997.304. Br J Cancer. 1997. PMID: 9192982 Free PMC article.

3

Genomic alterations in fallopian tube carcinoma: comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis.

Pere H, Tapper J, Seppälä M, Knuutila S, Butzow R. Pere H, et al. Among authors: butzow r. Cancer Res. 1998 Oct 1;58(19):4274-6. Cancer Res. 1998. PMID: 9766651

4

Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4.

Lassus H, Laitinen MP, Anttonen M, Heikinheimo M, Aaltonen LA, Ritvos O, Butzow R. Lassus H, et al. Among authors: butzow r. Lab Invest. 2001 Apr;81(4):517-26. doi: 10.1038/labinvest.3780260. Lab Invest. 2001. PMID: 11304571 Free article.

5

Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.

Lassus H, Salovaara R, Aaltonen LA, Butzow R. Lassus H, et al. Among authors: butzow r. Am J Pathol. 2001 Jul;159(1):35-42. doi: 10.1016/S0002-9440(10)61670-7. Am J Pathol. 2001. PMID: 11438451 Free PMC article.

6

Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients.

Moilanen J, Lassus H, Leminen A, Vaheri A, Bützow R, Carpén O. Moilanen J, et al. Among authors: butzow r. Gynecol Oncol. 2003 Aug;90(2):273-81. doi: 10.1016/s0090-8258(03)00262-2. Gynecol Oncol. 2003. PMID: 12893187

7

Glycodelin in ovarian serous carcinoma: association with differentiation and survival.

Mandelin E, Lassus H, Seppälä M, Leminen A, Gustafsson JA, Cheng G, Bützow R, Koistinen R. Mandelin E, et al. Among authors: butzow r. Cancer Res. 2003 Oct 1;63(19):6258-64. Cancer Res. 2003. PMID: 14559812

8

Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.

Erkinheimo TL, Lassus H, Sivula A, Sengupta S, Furneaux H, Hla T, Haglund C, Butzow R, Ristimäki A. Erkinheimo TL, et al. Among authors: butzow r. Cancer Res. 2003 Nov 15;63(22):7591-4. Cancer Res. 2003. PMID: 14633672

9

Distinct subtypes of serous ovarian carcinoma identified by p53 determination.

Lassus H, Leminen A, Lundin J, Lehtovirta P, Butzow R. Lassus H, et al. Among authors: butzow r. Gynecol Oncol. 2003 Dec;91(3):504-12. doi: 10.1016/j.ygyno.2003.08.034. Gynecol Oncol. 2003. PMID: 14675668

10

Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors.

Lehtonen R, Kiuru M, Vanharanta S, Sjöberg J, Aaltonen LM, Aittomäki K, Arola J, Butzow R, Eng C, Husgafvel-Pursiainen K, Isola J, Järvinen H, Koivisto P, Mecklin JP, Peltomäki P, Salovaara R, Wasenius VM, Karhu A, Launonen V, Nupponen NN, Aaltonen LA. Lehtonen R, et al. Among authors: butzow r. Am J Pathol. 2004 Jan;164(1):17-22. doi: 10.1016/S0002-9440(10)63091-X. Am J Pathol. 2004. PMID: 14695314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters